How virtual care, SaMD, chronic care, and provider-enablement startups raise capital in 2026 after the Teladoc/Livongo reset, GLP-1 disruption.
Digital health is in its third act. The 2020-2021 ZIRP wave burned out; the 2022-2024 correction cleared unprofitable virtual-care players (Cerebral, Amwell, Teladoc write-downs, Babylon collapse). What's left in 2026 is a discipline-first market: payer contracts with actuarially validated savings, employer channels with real utilization, SaMD with FDA clearance, and provider-enablement (RCM, ambient scribes, prior auth) that shows fast payback.
GLP-1s (Wegovy, Zepbound) reshaped cardiometabolic and obesity care — Noom, Omada, Virta, Hims, Ro all repositioned around GLP-1 wraparound. UnitedHealth's Change Healthcare cyberattack accelerated payer/provider tech consolidation. FDA cleared a growing catalog of AI/ML-enabled devices under the Predetermined Change Control Plan (PCCP). Ambient AI scribes (Abridge, Ambience, Nuance DAX, Suki) crossed $1B combined ARR and became the fastest-growing digital-health category ever.
Seed: $3-15M with a paid pilot or design partner. Series A: $15-60M with a signed payer/employer contract and validated savings. Series B: $50-200M for national scale and multi-payer coverage. Series C+: $150M-$700M for category leadership. Current references: Abridge, Ambience, Hinge Health, Omada, Sword Health, Virta, Included Health, Transcarent, Cohere, Waystar (IPO), Tempus (IPO).
Point-solution fatigue — employers and payers actively consolidate vendors. Vanity engagement metrics with no MLR/PMPM proof. Ignoring MSO/CPOM structure until a diligence blocker. Under-investing in claims data infrastructure. Selling to physicians directly with no payer/employer contract — sales cycles kill runway.
Investor directory · Fundraising library · Articles A–Z · Company funding database